These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11078361)

  • 1. Regulation of the myocardial endothelin system by angiotensin-II and losartan.
    McEwan PE; Sherry L; Kenyon CJ; Webb DJ; Gray GA
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S144-7. PubMed ID: 11078361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelin receptors in the hypertensive state of kinin B(2) knockout mice subjected to a high-salt diet.
    Brochu I; Labonté J; Bkaily G; D'Orléans-Juste P
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():380S-384S. PubMed ID: 12193127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
    Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids decrease endothelin-A- and -B-receptor expression in the kidney.
    Villeneuve A; Gignac S; Provencher PH
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S238-40. PubMed ID: 11078386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
    Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Miyauchi T; Nishikibe M
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.
    Ito H; Hirata Y; Adachi S; Tanaka M; Tsujino M; Koike A; Nogami A; Murumo F; Hiroe M
    J Clin Invest; 1993 Jul; 92(1):398-403. PubMed ID: 8326007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes: acute effects of mixed ET(A)/ET(B) and AT1 receptor antagonists in vivo and in vitro.
    Magga J; Vuolteenaho O; Marttila M; Ruskoaho H
    Circulation; 1997 Nov; 96(9):3053-62. PubMed ID: 9386175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of renin-angiotensin and endothelin systems in development of diastolic heart failure in hypertensive hearts.
    Yamamoto K; Masuyama T; Sakata Y; Mano T; Nishikawa N; Kondo H; Akehi N; Kuzuya T; Miwa T; Hori M
    Cardiovasc Res; 2000 Aug; 47(2):274-83. PubMed ID: 10946064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
    Richard V; Hogie M; Thuillez C
    Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro.
    Hirata Y; Kanno K; Eguchi S; Kano H
    Blood Press Suppl; 1994; 5():84-8. PubMed ID: 7889209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
    Leskinen H; Vuolteenaho O; Ruskoaho H
    Circ Res; 1997 Jan; 80(1):114-23. PubMed ID: 8978330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trophic effect of angiotensin II in neonatal rat cardiomyocytes: role of endothelin-1 and non-myocyte cells.
    Pönicke K; Heinroth-Hoffmann I; Becker K; Brodde OE
    Br J Pharmacol; 1997 May; 121(1):118-24. PubMed ID: 9146895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension.
    Alexander BT; Cockrell KL; Rinewalt AN; Herrington JN; Granger JP
    Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1388-92. PubMed ID: 11294758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitor and AT1 antagonist blockade of deformation-induced gene expression in the rabbit jugular vein through B2 receptor activation.
    Lauth M; Cattaruzza M; Hecker M
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):61-6. PubMed ID: 11145934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of losartan on angiotensin II-mediated endothelin and prostanoid excretion in humans.
    Quest DW; Gopalakrishnan V; McNeill JR; Wilson TW
    Am J Hypertens; 2000 Dec; 13(12):1288-94. PubMed ID: 11130773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial expression of the endothelin system in endotoxin-treated rats.
    Spiers JP; Dorman A; Allen JD; Kelso EJ; Silke B; McDermott BJ
    J Cardiovasc Pharmacol; 2001 Aug; 38(2):259-67. PubMed ID: 11483876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats.
    Oie E; Vinge LE; Tønnessen T; Grøgaard HK; Kjekshus H; Christensen G; Smiseth OA; Attramadal H
    Am J Physiol; 1997 Oct; 273(4):H1727-36. PubMed ID: 9362237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelin and isoprostanes in slow pressor responses to angiotensin II.
    Ortiz MC; Sanabria E; Manriquez MC; Romero JC; Juncos LA
    Hypertension; 2001 Feb; 37(2 Pt 2):505-10. PubMed ID: 11230326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.
    Kobayashi T; Nogami T; Taguchi K; Matsumoto T; Kamata K
    Br J Pharmacol; 2008 Dec; 155(7):974-83. PubMed ID: 19029977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.